cap-232
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2007 (NCT00422786)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cap-232
- cap-232
- tln-232
- tln-232
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00735332 | Phase 2 | Aug 1, 2008 | Thallion Pharmaceuticals, University of Toronto |
| NCT00422786 | Phase 2 | Mar 1, 2007 | Thallion Pharmaceuticals, University of Montpellier |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Thallion Pharmaceuticals | For profit | 2 | 2 | 1 | 2007 |
| University of Montpellier | Academic/Hospital | 1 | 0 | 1 | 2007 |
| University of Toronto | Academic/Hospital | 1 | 0 | 1 | 2008 |
3 organizations
Page 1 / 1